ALVOGEN PARTNERS WITH ROBERT WESSMAN TO BUILD A LEADING INTERNATIONAL GENERICS COMPANY
New Jersey, July 29, 2009. Alvogen Group, the New Jersey-based generic pharmaceutical company, today announces that Robert Wessman, former CEO of Actavis, one of the world’s leading generic pharmaceutical companies, has become Executive Chairman. At the same time, Mr. Ghiath Sukhtian, Chairman of Alvogen, Mr. Wessman and AFI Partners, a US-based private equity firm, have unveiled plans to substantially grow Alvogen globally and build the next generation international generic